Otto SJ - Search Results

1

Limited contamination in the Dutch-Belgian randomized lung cancer screening trial (NELSON).

Baecke E, de Koning HJ, Otto SJ, van Iersel CA, van Klaveren RJ. Baecke E, et al. Among authors: otto sj. Lung Cancer. 2010 Jul;69(1):66-70. doi: 10.1016/j.lungcan.2009.08.015. Epub 2009 Oct 3. Lung Cancer. 2010. PMID: 19801174

2

Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer.

Otto SJ, van der Cruijsen IW, Liem MK, Korfage IJ, Lous JJ, Schröder FH, de Koning HJ. Otto SJ, et al. Int J Cancer. 2003 Jun 20;105(3):394-9. doi: 10.1002/ijc.11074. Int J Cancer. 2003. PMID: 12704675 Clinical Trial.

3

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review.

Otto SJ, Fracheboud J, Looman CW, Broeders MJ, Boer R, Hendriks JH, Verbeek AL, de Koning HJ; National Evaluation Team for Breast Cancer Screening. Otto SJ, et al. Lancet. 2003 Apr 26;361(9367):1411-7. doi: 10.1016/S0140-6736(03)13132-7. Lancet. 2003. PMID: 12727393 Review.

4

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, de Koning HJ. Draisma G, et al. Among authors: otto sj. J Natl Cancer Inst. 2003 Jun 18;95(12):868-78. doi: 10.1093/jnci/95.12.868. J Natl Cancer Inst. 2003. PMID: 12813170 Free article. Clinical Trial.

5

Update on screening and early detection of prostate cancer.

Otto SJ, de Koning HJ. Otto SJ, et al. Curr Opin Urol. 2004 May;14(3):151-6. doi: 10.1097/00042307-200405000-00003. Curr Opin Urol. 2004. PMID: 15069305 Review.

6

Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?

Otto SJ, Schröder FH, de Koning HJ. Otto SJ, et al. J Med Screen. 2004;11(2):89-92. doi: 10.1258/096914104774061074. J Med Screen. 2004. PMID: 15153324 Clinical Trial.

7

Decreased rates of advanced breast cancer due to mammography screening in The Netherlands.

Fracheboud J, Otto SJ, van Dijck JA, Broeders MJ, Verbeek AL, de Koning HJ; National Evaluation Team for Breast cancer screening (NETB). Fracheboud J, et al. Among authors: otto sj. Br J Cancer. 2004 Aug 31;91(5):861-7. doi: 10.1038/sj.bjc.6602075. Br J Cancer. 2004. PMID: 15292936 Free PMC article.

8

Overall and disease-specific survival of patients with screen-detected prostate cancer in the European randomized study of screening for prostate cancer, section Rotterdam.

de Vries SH, Postma R, Raaijmakers R, Roemeling S, Otto S, de Koning HJ, Schröder FH. de Vries SH, et al. Eur Urol. 2007 Feb;51(2):366-74; discussion 374. doi: 10.1016/j.eururo.2006.07.052. Epub 2006 Aug 15. Eur Urol. 2007. PMID: 16930812 Review.

9

Risk of cardiovascular mortality in prostate cancer patients in the Rotterdam randomized screening trial.

Otto SJ, Schröder FH, de Koning HJ. Otto SJ, et al. J Clin Oncol. 2006 Sep 1;24(25):4184-9. doi: 10.1200/JCO.2005.05.4288. J Clin Oncol. 2006. PMID: 16943535

10

Feasibility study of adjustment for contamination and non-compliance in a prostate cancer screening trial.

Roemeling S, Roobol MJ, Otto SJ, Habbema DF, Gosselaar C, Lous JJ, Cuzick J, Schröder FH. Roemeling S, et al. Among authors: otto sj. Prostate. 2007 Jul 1;67(10):1053-60. doi: 10.1002/pros.20606. Prostate. 2007. PMID: 17458908 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters